Vilevev MB Interactions
There are 759 drugs known to interact with Vilevev MB (hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate), along with 37 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 257 are major, 487 are moderate, and 15 are minor.
- View all 759 medications that may interact with Vilevev MB
- View Vilevev MB alcohol/food interactions (3)
- View Vilevev MB disease interactions (37)
Most frequently checked interactions
View interaction reports for Vilevev MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate) and the medicines listed below.
- Advair HFA (fluticasone / salmeterol)
- Ambien (zolpidem)
- Atarax (hydroxyzine)
- baclofen
- celecoxib
- cetirizine
- clonazepam
- cyclobenzaprine
- Dexilant (dexlansoprazole)
- Dupixent (dupilumab)
- Dymista (azelastine / fluticasone nasal)
- hydroxyzine
- Jardiance (empagliflozin)
- Latuda (lurasidone)
- losartan
- Lumigan (bimatoprost ophthalmic)
- Lyrica (pregabalin)
- modafinil
- montelukast
- Mounjaro (tirzepatide)
- Namenda XR (memantine)
- Paxlovid (nirmatrelvir / ritonavir)
- phentermine
- prednisone
- Reglan (metoclopramide)
- Restasis (cyclosporine ophthalmic)
- Seroquel (quetiapine)
- sulfamethoxazole / trimethoprim
- sumatriptan
- Symbicort (budesonide / formoterol)
Vilevev MB alcohol/food interactions
There are 3 alcohol/food interactions with Vilevev MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate).
Vilevev MB disease interactions
There are 37 disease interactions with Vilevev MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- inflammatory bowel disease
- intestinal obstruction disorders
- crystalluria
- gout
- liver disease
- methemoglobinemia in G-6-PD
- hypocalcemia
- phosphate imbalance
- GI toxicity
- renal dysfunction
- Reye's syndrome
- electrolyte imbalance
- cardiac disease
- tachycardia
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- liver disease
- renal failure
- renal dysfunction
- anemia
- coagulation
- dialysis
- G-6-PD deficiency
- hepatotoxicity
- hypertension
- hyperthyroidism
- diarrhea
- fever
Report options
More about Vilevev MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Vilevev MB consumer information
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Drug class: urinary antispasmodics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.